This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Utah Research Foundation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Khaled Greish: Innovator in Cancer Gene Therapy
Introduction
Khaled Greish is a prominent inventor based in Salt Lake City, UT. He has made significant contributions to the field of cancer gene therapy through his innovative research and development of advanced delivery systems.
Latest Patents
Khaled Greish holds a patent for "Matrix metalloproteinase cleavable protein polymers for cancer gene therapy." This delivery system includes a recombinantly synthesized protein polymer with protease cleavage sites, such as matrix metalloproteinase responsive sequences engineered within the protein polymer. The system is designed to treat cancer, wounds, or pathological conditions in tissues that express excess protease relative to healthy tissue. He has 1 patent to his name.
Career Highlights
Khaled Greish is affiliated with the University of Utah Research Foundation, where he continues to advance his research in the field of gene therapy. His work focuses on developing innovative solutions that can improve treatment outcomes for patients suffering from cancer and other related conditions.
Collaborations
Khaled has collaborated with notable colleagues, including Hamidreza Ghandehari and Joseph Cappello, to further enhance the impact of his research and innovations.
Conclusion
Khaled Greish is a dedicated inventor whose work in cancer gene therapy exemplifies the potential of innovative research to transform medical treatments. His contributions are paving the way for new therapeutic strategies that could significantly benefit patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile